Search research articles
Contact Us
Filters
Showing results (211-220 of 264) with videos related to
Page
of 27
Sort By:
Cancer Discovery
|
April 7, 2021
Clinical Acquired Resistance to KRAS<sup>G12C</sup> Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation
Noritaka Tanaka, Jessica J Lin, Chendi Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2021
Screening and Validation of Molecular Targeted Radiosensitizers
Henning Willers, Xiao Pan, Nathalie Borgeaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2016
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
Justin F Gainor, Alice T Shaw, Lecia V Sequist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2018
Increased Synthesis of MCL-1 Protein Underlies Initial Survival of <i>EGFR</i>-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target
Kyung-A Song, Yasuyuki Hosono, Crystal Turner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
J J Lin, S V Liu, C E McCoach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition
Sandra Misale, Jackson P Fatherree, Eliane Cortez, et al.
NPJ Precision Oncology
|
August 18, 2020
Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibition
Jessica J Lin, Adam Langenbucher, Pranav Gupta, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
A cellular and spatial atlas of <i>TP53</i> -associated tissue remodeling in lung adenocarcinoma
William Zhao, Benjamin Kepecs, Navin R Mahadevan, et al.
Nature Cancer
|
June 21, 2022
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer
Aya Shiba-Ishii, Ted W Johnson, Ibiayi Dagogo-Jack, et al.
JCO Precision Oncology
|
August 21, 2018
Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung Cancer
Zofia Piotrowska, Mehlika Hazar-Rethinam, Coleen Rizzo, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 264) with videos related to
Sort By:
Page
of 27
Cancer Discovery
|
April 7, 2021
Clinical Acquired Resistance to KRAS<sup>G12C</sup> Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation
Noritaka Tanaka, Jessica J Lin, Chendi Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2021
Screening and Validation of Molecular Targeted Radiosensitizers
Henning Willers, Xiao Pan, Nathalie Borgeaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2016
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
Justin F Gainor, Alice T Shaw, Lecia V Sequist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2018
Increased Synthesis of MCL-1 Protein Underlies Initial Survival of <i>EGFR</i>-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target
Kyung-A Song, Yasuyuki Hosono, Crystal Turner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
J J Lin, S V Liu, C E McCoach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition
Sandra Misale, Jackson P Fatherree, Eliane Cortez, et al.
NPJ Precision Oncology
|
August 18, 2020
Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibition
Jessica J Lin, Adam Langenbucher, Pranav Gupta, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
A cellular and spatial atlas of <i>TP53</i> -associated tissue remodeling in lung adenocarcinoma
William Zhao, Benjamin Kepecs, Navin R Mahadevan, et al.
Nature Cancer
|
June 21, 2022
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer
Aya Shiba-Ishii, Ted W Johnson, Ibiayi Dagogo-Jack, et al.
JCO Precision Oncology
|
August 21, 2018
Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung Cancer
Zofia Piotrowska, Mehlika Hazar-Rethinam, Coleen Rizzo, et al.
Page
of 27